About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- Routine practices apply to every patient encounter: hand hygiene, point-of-care risk assessment, PPE, sharps safety, cleaning and respiratory etiquette
- Additional precautions are transmission-based: contact, droplet and airborne precautions are added when required
- Antimicrobial stewardship means right drug, dose, route and duration — and no antibiotic when bacterial infection is unlikely
- Cultures should be obtained before antibiotics when they will change management and treatment will not be dangerously delayed
- De-escalation, IV-to-oral switch and shorter effective durations are core stewardship principles
Approach to the Presentation
This presentation is how clinicians prevent harm at the system level. PHAC routine practices and additional precautions guide infection prevention in healthcare settings. The approach begins with a point-of-care risk assessment: body fluids, respiratory symptoms, rash, diarrhoea, draining wounds and aerosol-generating procedures. Apply routine practices for all patients and additional precautions for suspected transmission routes. Antimicrobial stewardship runs in parallel: diagnose accurately, avoid unnecessary antibiotics, choose empiric therapy rationally, narrow when results return, switch to oral therapy when safe and stop therapy when infection is not present.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Airborne-transmitted infection | must-not-miss | Cough with TB risk, febrile rash illness, measles exposure, varicella/disseminated zoster; high transmission risk | Syndrome recognition plus airborne isolation; organism-specific PCR/culture/serology/public health testing |
| C. difficile infection | must-not-miss | Watery diarrhoea after antibiotics/healthcare exposure, abdominal pain, fever, leukocytosis or severe colitis | Stool toxin/NAAT algorithm; do not test formed stool |
| Droplet-transmitted respiratory infection | common | Influenza-like illness, meningococcal disease, pertussis and many respiratory viruses | Respiratory PCR/culture as indicated; apply droplet precautions |
| Contact-transmitted infection / MDRO | common | C. difficile diarrhoea, MRSA, VRE, draining wounds or resistant Gram-negatives | Stool testing/cultures/screening based on local policy; contact precautions |
| Antibiotic allergy label causing suboptimal therapy | common | Remote vague penicillin allergy label leading to broad-spectrum alternatives and resistance/toxicity | Detailed allergy history; delabelling/testing pathway when appropriate |
| Colonization rather than infection | common | Positive urine/wound/sputum culture without compatible symptoms or inflammatory findings | Clinical correlation; avoid treating asymptomatic bacteriuria except specific indications |
| Viral syndrome treated with antibiotics | common | URTI/bronchitis-like symptoms without bacterial features; patient expectation may drive prescribing | Clinical diagnosis and safety-netting; viral testing when it changes management |
| Device-associated infection | less common | Catheter, central line, ventilator, prosthetic joint/valve or surgical implant with fever/local signs | Device/site cultures, blood cultures, imaging and source-control assessment |
Red Flags & Key History
Symptoms
Cough with TB risk, measles-like rash, varicella/disseminated zoster — airborne precautions now
Acute diarrhoea after antibiotics or healthcare exposure — possible C. difficile
Meningococcal disease suspicion — droplet precautions, urgent antibiotics and public health notification
Outbreak cluster, unusual resistance pattern or high-consequence pathogen
Positive culture without symptoms — consider colonization/contamination before treating
Ask about recent antibiotics, hospitalisation, long-term care, travel healthcare, devices and prior resistant organisms
Signs
Point-of-care risk assessment: body fluids, cough, diarrhoea, rash, draining wounds and aerosol risk
Signs of severe infection or sepsis requiring immediate empiric therapy
Infectious diarrhoea with dehydration, toxic megacolon or severe abdominal tenderness
Rash with fever in an unimmunized patient or exposure setting
Approach to Investigation
First-line
Point-of-care risk assessmentDetermines PPE and need for contact/droplet/airborne precautions before definitive diagnosis
Culture before antibiotics when useful and safeBlood, urine, sputum, wound or CSF cultures when results will affect management; do not delay therapy in sepsis
Medication/allergy reviewClarify true allergy, renal function, interactions, prior antibiotics and colonization history
Syndrome-specific diagnosticsAvoid broad testing panels without a question; test when the result changes isolation, treatment or public health action
Second-line
Antibiotic time-out at 48-72 hoursReview cultures, diagnosis, response, route, dose and duration; narrow, stop or switch oral when appropriate
Resistance/colonization screeningMRSA/VRE/CRE or other screening based on local infection-control policy and risk
Outbreak investigation testsUse infection prevention/public health direction for clusters, high-consequence pathogens or unusual resistance
Specialist
Infection prevention and control teamFor isolation decisions, exposures, outbreaks, PPE policy and healthcare-associated infection prevention
Antimicrobial stewardship / infectious diseases / microbiologyFor broad-spectrum therapy, resistant organisms, complex infections, OPAT or de-escalation uncertainty
Management Principles
PHAC Routine Practices and Additional Precautions + PHAC AMR guidance + Choosing Wisely Canada/AMMI stewardship1
Routine practices
- Hand hygiene before and after patient contact
- Point-of-care risk assessment before every interaction
- Gloves, gown, mask/eye protection based on anticipated exposure
- Safe sharps, respiratory etiquette, environmental cleaning and equipment reprocessing
2
Additional precautions
- Contact: C. difficile, uncontrolled drainage and many MDROs; use gown/gloves and dedicated equipment as directed
- Droplet: respiratory pathogens transmitted at close range; mask/eye protection and room placement per policy
- Airborne: TB, measles, varicella/disseminated zoster; airborne isolation and fit-tested respirator where indicated
3
Stewardship prescribing
- Avoid antibiotics for viral URTI/bronchitis and asymptomatic bacteriuria except specific indications
- Use the narrowest effective regimen once diagnosis and susceptibilities are known
- Switch from IV to oral therapy when improving, able to absorb and an oral option is appropriate
- Document indication, planned duration and reassessment point
4
Systems and public health
- Report notifiable diseases according to jurisdiction
- Use audit/feedback, local antibiograms and clinical pathways
- Communicate isolation status and pending cultures at transitions of care
Complications & Pitfalls
- Treating colonization: Positive cultures need symptoms and clinical correlation.
- Forgetting hand hygiene: The simplest intervention is often highest yield.
- Wrong isolation: TB/measles/varicella need airborne precautions; diarrhoeal illness often needs contact precautions.
- No antibiotic time-out: Empiric broad therapy should be reassessed at 48-72 hours.
- Ignoring route: IV therapy is not required when a highly bioavailable oral agent is appropriate.
MCCQE1 Exam Tips
- 1MCCQE1 infection-control questions often ask for route: contact, droplet or airborne. TB/measles/varicella = airborne
- 2Routine practices apply to every patient, not only known infections
- 3C. difficile: contact precautions and stool testing only if diarrhoea; do not test formed stool
- 4Stewardship pattern: culture when useful, start empiric therapy if severe, then narrow/stop/switch oral at reassessment
- 5Asymptomatic bacteriuria is usually not treated except pregnancy or before selected urologic procedures
- 6Choosing Wisely/AMMI principle: do not use IV antibiotics when safe effective oral therapy is available
- 7Public health notification is a management step, not an optional administrative afterthought
practicetest your knowledge on infection control & antimicrobial stewardshipApply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — infectious disease and beyond.
open q-bank